Will plant-made biopharmaceuticals play a role in the fight against COVID-19?
Identifieur interne : 000060 ( 2020/Analysis ); précédent : 000059; suivant : 000061Will plant-made biopharmaceuticals play a role in the fight against COVID-19?
Auteurs : Sergio Rosales-Mendoza [Mexique]Source :
- Expert opinion on biological therapy [ 1744-7682 ] ; 2020.
Abstract
Given the dramatic impact of the COVID-19 pandemic, it is imperative to divulge all the available technologies with the potential to fight against this virus. Plant biotechnology offers potential solutions to this pandemic through the development of low-cost vaccines and antibodies useful for therapy, prophylaxis, and diagnosis. The technology to produce plant-made biopharmaceuticals is already established; two examples of these are: a therapeutic enzyme that has entered the market and the influenza vaccines that are currently under clinical trials with encouraging results. Thus far, some companies have started developing anti-COVID-19 antibodies and vaccines. In particular, plant-made antibodies might be timely produced and approved for human use in the short term, while the development of vaccines will take longer time (clinical evaluations could be concluded by the end of 2021); nonetheless, the candidates obtained will be valuable tools for future outbreaks. The key aspects that will define the exploitation of this technology in the fight against COVID-19 are discussed.
DOI: 10.1080/14712598.2020.1752177
PubMed: 32250170
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000344
- to stream PubMed, to step Curation: 000344
- to stream PubMed, to step Checkpoint: 000046
- to stream Ncbi, to step Merge: 003755
- to stream Ncbi, to step Curation: 003755
- to stream Ncbi, to step Checkpoint: 003755
- to stream Main, to step Merge: 000060
- to stream Main, to step Curation: 000060
- to stream Main, to step Exploration: 000060
- to stream 2020, to step Extraction: 000060
Links to Exploration step
pubmed:32250170Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Will plant-made biopharmaceuticals play a role in the fight against COVID-19?</title><author><name sortKey="Rosales Mendoza, Sergio" sort="Rosales Mendoza, Sergio" uniqKey="Rosales Mendoza S" first="Sergio" last="Rosales-Mendoza">Sergio Rosales-Mendoza</name><affiliation wicri:level="1"><nlm:affiliation>Facultad De Ciencias Químicas, Universidad Autónoma De San Luis Potosí, San Luis Potosí, México.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Mexique</country><wicri:regionArea>Facultad De Ciencias Químicas, Universidad Autónoma De San Luis Potosí, San Luis Potosí</wicri:regionArea><wicri:noRegion>San Luis Potosí</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32250170</idno><idno type="pmid">32250170</idno><idno type="doi">10.1080/14712598.2020.1752177</idno><idno type="wicri:Area/PubMed/Corpus">000344</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000344</idno><idno type="wicri:Area/PubMed/Curation">000344</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000344</idno><idno type="wicri:Area/PubMed/Checkpoint">000046</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000046</idno><idno type="wicri:Area/Ncbi/Merge">003755</idno><idno type="wicri:Area/Ncbi/Curation">003755</idno><idno type="wicri:Area/Ncbi/Checkpoint">003755</idno><idno type="wicri:Area/Main/Merge">000060</idno><idno type="wicri:Area/Main/Curation">000060</idno><idno type="wicri:Area/Main/Exploration">000060</idno><idno type="wicri:Area/2020/Extraction">000060</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Will plant-made biopharmaceuticals play a role in the fight against COVID-19?</title><author><name sortKey="Rosales Mendoza, Sergio" sort="Rosales Mendoza, Sergio" uniqKey="Rosales Mendoza S" first="Sergio" last="Rosales-Mendoza">Sergio Rosales-Mendoza</name><affiliation wicri:level="1"><nlm:affiliation>Facultad De Ciencias Químicas, Universidad Autónoma De San Luis Potosí, San Luis Potosí, México.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Mexique</country><wicri:regionArea>Facultad De Ciencias Químicas, Universidad Autónoma De San Luis Potosí, San Luis Potosí</wicri:regionArea><wicri:noRegion>San Luis Potosí</wicri:noRegion></affiliation></author></analytic><series><title level="j">Expert opinion on biological therapy</title><idno type="eISSN">1744-7682</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Given the dramatic impact of the COVID-19 pandemic, it is imperative to divulge all the available technologies with the potential to fight against this virus. Plant biotechnology offers potential solutions to this pandemic through the development of low-cost vaccines and antibodies useful for therapy, prophylaxis, and diagnosis. The technology to produce plant-made biopharmaceuticals is already established; two examples of these are: a therapeutic enzyme that has entered the market and the influenza vaccines that are currently under clinical trials with encouraging results. Thus far, some companies have started developing anti-COVID-19 antibodies and vaccines. In particular, plant-made antibodies might be timely produced and approved for human use in the short term, while the development of vaccines will take longer time (clinical evaluations could be concluded by the end of 2021); nonetheless, the candidates obtained will be valuable tools for future outbreaks. The key aspects that will define the exploitation of this technology in the fight against COVID-19 are discussed.</div></front></TEI><affiliations><list><country><li>Mexique</li></country></list><tree><country name="Mexique"><noRegion><name sortKey="Rosales Mendoza, Sergio" sort="Rosales Mendoza, Sergio" uniqKey="Rosales Mendoza S" first="Sergio" last="Rosales-Mendoza">Sergio Rosales-Mendoza</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/2020/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000060 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd -nk 000060 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= 2020
|étape= Analysis
|type= RBID
|clé= pubmed:32250170
|texte= Will plant-made biopharmaceuticals play a role in the fight against COVID-19?
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/RBID.i -Sk "pubmed:32250170" \
| HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |